TrialLeukemia & lymphoma2020

A phase II clinical trial of lenalidomide intensification in patients with serologic/asymptomatic progression of multiple myeloma while on lenalidomide maintenance: a tri-state transplant consortium study.

Hani Hassoun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.